Wake Forest University Health Sciences
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Wake Forest University Health Sciences sits in the top decile of US sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count).
Wake Forest University Health Sciences: 1,140 sponsored US clinical trials, 174 recruiting.
Wake Forest University Health Sciences sponsors 1,140 registered US clinical trials on ClinicalTrials.gov, 174 of them currently recruiting, and 724 completed. 111 of these trials are in Phase 3-4 (later-stage) and 239 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 9 trials.
Top-decile sponsor footprint
Wake Forest University Health Sciences ranks in the top decile of sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
724 of 885 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,140 total, page 15 of 23
Programs To Support You During Chemotherapy
NCT02489422
Assessing the Feasibility of the Use of Visual Aids in Patient Education in Adults With Down Syndrome (DS)
NCT02895802
Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver Metastases
NCT02866344
Comprehensive Post-Acute Stroke Services
NCT02588664
Pre-hospital Advanced Therapies for Control of Hemorrhage - Pelvis
NCT02855060
Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung Cancer
NCT02581943
Predicting, Understanding and Speeding Recovery After TKA
NCT02685735
Family-Centered Cesarean Delivery
NCT02690077
Vitamin D Deficiency and Dysautonomia
NCT03032328
Effect of Mentoring on Endotracheal Tube Exchange Using a New Device
NCT02763189
Tourniquet Pressure in Primary Total Knee Arthroplasty
NCT02830087
Pain Effect on Attention Using an Ipad Game App
NCT03115788
Changes in Circulating Tumor-Specific DNA in Patients With Non-Metastatic Non-Small Cell Lung Cancer
NCT03746262
Internet Surveys and Their Impact on Adherence for Rosacea
NCT03048058
Palliative Radiation Therapy in Reducing Pain in Patients With Bone Metastasis
NCT02699697
Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors
NCT02747407
Power Morcellation Systems for Laparoscopic Hysterectomy and Myomectomy
NCT02777203
Psychosocial Stress and Aging in HIV
NCT02965469
Bedside Ultrasound to Measure Optic Nerve Sheath Diameter in Pediatric CSF Shunts
NCT02776085
Paclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial Cancer
NCT02581982
Prehabilitation Using Aquatic Exercise
NCT02773745
Intranasal Insulin and Post-stroke Cognition: A Pilot Study
NCT02810392
Oral Psoriasis Treatment Adherence and Intervention Study
NCT02850900
Analgesic Benefit of PECS Blocks for Biceps Tenodesis Shoulder Surgery
NCT02741713
Lutonix or Inpact for tHE tReatment Of fEmeropopliteal Stenosis - Drug Coated Balloon
NCT02812966
Efficacy of Ginseng for Patients on Regorafenib
NCT02581059
Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery
NCT02583269
Assessment of Infection Control, Practice Efficiency, and Health Economics of Sheathed Versus Standard Cystoscopy
NCT02922868
The Efficacy of Cranial Electrostimulating Therapy for Depression and Anxiety Among Homeless Adults
NCT02732561
TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma
NCT02704130
Video vs. Direct Laryngoscopy in Pediatric Nasal Intubation
NCT03032263
Community Hospital Identification of High CV Risk Patients During Cancer Treatment
NCT02566109
Aiming to Improve Readmissions Through InteGrated Hospital Transitions
NCT02763202
Dietary Acid Load, Kidney Function and Disability in Elderly
NCT02691663
A Pilot Study Comparing Anti-Inflammatory Effects Of TXA Versus EACA In Pediatric Congenital Heart Surgery
NCT02656472
Take the Fight in Supporting and Empowering Patients With Cancer
NCT02729883
An Evaluation Of The Novel TRAMINER Sequence By Comparison To Late Gadolinium Enhancement Images
NCT02727725
Attitudes and Knowledge Regarding Clinical Trials in Underserved Populations Receiving Care at the Comprehensive Cancer Center of Wake Forest University
NCT02444754
Controlled Trial to Compare Single Versus Two Portal Knee Arthroscopy Techniques
NCT02648971
Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
NCT02582008
Effects of Strength Training on Musculoskeletal Overuse Injuries in Female Runners
NCT03080246
IN Sub-Dissociative Ketamine vs IN Fentanyl
NCT02521415
Pre-Shave Gel and Brush in Pseudofolliculitis Barbae
NCT03043534
The Use of Integra in Coverage of Radial Forearm Free Flap Donor Site Defect
NCT02980601
Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery
NCT02566421
CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma
NCT02484391
LCI-NOS-PAIN-001: A Prospective, Pharmacogenomic-Driven Study of Pain Management in Oncology Outpatients
NCT02542397
OSA Screen Negative With Spinal Duramorph
NCT03151226
Static Magnetic Therapy for Carpal Tunnel Syndrome
NCT02609113
Exercise Intolerance in Elderly Patients With HFpEF(Heart Failure With Preserved Ejection Fraction)
NCT02636439
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 96 |
| Phase 2 | 143 |
| Phase 3 | 31 |
| Phase 4 | 80 |
Therapeutic Areas
What is open in the Wake Forest University Health Sciences pipeline
174 recruiting of 1,140 indexed (15% open); 724 completed (64%).
Phase mix: 111 late (III/IV) vs 239 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Wake Forest University Health Sciences: open-pipeline peers nationwide
Peers matched on 1,140 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Wake Forest University Health Sciences sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,140 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- University of Florida · 1,106 trials · 15% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
Related
What to do with this Wake Forest University Health Sciences page
1,140 registered trials is a research-attention snapshot, not an endorsement of Wake Forest University Health Sciences or any single study.
- 174 of Wake Forest University Health Sciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Wake Forest University Health Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Wake Forest University Health Sciences pipeline card: 1,140 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.